You are here

AstraZeneca

AstraZeneca’s Victory Highlights Difficulty Of Cancer Drug Development

Forbes

Wed, 04/6/11 - 07:46 pm

drug development

Dividend Sector Review: Pharmaceuticals

Motley Fool

Thu, 03/31/11 - 10:15 pm

Abbott Laboratories

[video] AZN Increases Target, MENT Rejects Icahn

Forbes

Mon, 03/28/11 - 05:49 pm

AstraZeneca lifts earnings guidances after tax deal

Marketwatch

Mon, 03/28/11 - 09:47 am

Top 5 Pharmaceuticals Paying Excellent Dividends

Seeking Alpha

Sun, 03/27/11 - 12:10 pm

Bristol-Myers Squibb

Novartis Has Largest Japan Exposure Among Big Pharma

Barron's

Tue, 03/15/11 - 11:08 am

Bristol-Myers Squibb

AstraZeneca to Pay $68.5 Million to States Over Seroquel

Bloomberg

Thu, 03/10/11 - 12:15 pm

What's Pozen Really Worth?

Seeking Alpha

Tue, 03/8/11 - 05:59 pm

FDA accepts application for Astra diabetes drug

Yahoo/AP

Tue, 03/8/11 - 09:36 am

Bristol-Myers Squibb

AstraZeneca ends production of Pulmicort inhaler, hitting shares in partner SkyePharma

Yahoo/AP

Mon, 03/7/11 - 10:44 am

Pharma's Newest Acquisition Targets

Motley Fool

Tue, 03/1/11 - 09:10 am

Four High Yield Drug Stocks With Upside Potential

Seeking Alpha

Mon, 02/28/11 - 12:09 pm

Bristol-Myers Squibb

AZ's dental unit attracts a slew of suitors

Fierce Pharma

Thu, 02/24/11 - 11:40 pm

PDL Settles MedImmune Dispute

Yahoo/Zacks.com

Fri, 02/18/11 - 03:17 pm

Abbott Laboratories

AstraZeneca Said to Pay $150 Million to Settle Seroquel Suits

Bloomberg

Thu, 02/17/11 - 09:02 am

The Next Big Pharma Share?

Motley Fool

Fri, 02/11/11 - 07:44 am

FDA Says Drug Firms Didn't Finish Follow-Ups

WSJ Online

Wed, 02/9/11 - 11:16 am

How a Single Patent Expiry Could Wipe Out 40% of AstraZeneca’s Profits

BNET Pharma

Tue, 02/8/11 - 11:51 am

Zibotentan Stopped, Long Live Provenge (for Now)

Motley Fool

Mon, 02/7/11 - 07:27 pm

prostate cancer

Drugs for Schizophrenia May Lead to Brain Tissue Loss

Bloomberg

Mon, 02/7/11 - 07:25 pm

Pages